About this data
What it is
ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
Who files it
The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
How current
We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
Terms
ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
Worth knowing
A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
Not to be confused with
FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.

All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.

Studies updated per day, last 30 days

0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0
0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0

All industry-sponsored studies Sponsor matched to a public company

By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.

Latest clinical trial updates

Reset

Showing: ticker TNDM · All recent updates

Studies by the date their record was last updated.

Latest clinical trial updates
UpdatedStudySponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).EnrolledPrimary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.Source
Oct 14, 2026The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
NCT07211126 · Diabetes Mellitus, Type 1
t:slim X2 insulin pump with Control-IQ technology (Control-…
TNDM
Tandem Diabetes Care, Inc.
—Recruiting350Dec 2027Registry ↗
Sep 1, 2026PS230005 Control-IQ 1.5 Post-Approval Study
NCT06717451 · Type 1 Diabetes
Control-IQ Technology v1.5
TNDM
Tandem Diabetes Care, Inc.
—Completed144Aug 10, 2026Registry ↗
Aug 31, 2026Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type…
NCT07325461 · Diabetes Mellitus, Type 1
SteadiSet Infusion Set
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted20Jun 24, 2026Registry ↗
Jun 24, 2026Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study
NCT05014789 · Diabetes Mellitus, Type 1
Control-IQ technology 2.0
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted66Dec 20, 2021Registry ↗
May 22, 2026A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
NCT05785832 · Type 2 Diabetes Treated With Insulin
t:slim X2 insulin pump with Control-IQ+ technology and Dexc…
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted319Sep 24, 2024Registry ↗
May 5, 2026Tandem Freedom - Feasibility Trial 2
NCT06834568 · Diabetes Mellitus, Type 1
t:slim X2 insulin pump with Tandem Freedom Algorithm
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted10Apr 7, 2025Registry ↗
Nov 18, 2025Tandem Freedom Feasibility Study 1
NCT06428591 · Diabetes Mellitus, Type 1
t:slim X2 insulin pump with Tandem Freedom Algorithm
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted10Jun 10, 2024Registry ↗
Sep 24, 2025Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes
NCT06273124 · Type1diabetes
SteadiSet Extended Wear Infusion Set
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted260Dec 11, 2024Registry ↗
Apr 3, 2025Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)
NCT05422053 · Type 1 Diabetes
t:slim X2 insulin pump with Control-IQ technology 1.5
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted34Jan 6, 2023Registry ↗
Dec 20, 2024Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes
NCT05683392 · Type 1 Diabetes
t:slim X2 insulin pump with Control-IQ technology 2.0
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted72Dec 13, 2023Registry ↗
Jul 26, 2024Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2…
NCT05403502 · Type 1 Diabetes
t:slim X2 insulin pump with Control-IQ technology 1.5
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted183Aug 2, 2023Registry ↗
Apr 5, 2024Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use
NCT05204134 · Type 1 Diabetes
Automated Insulin Delivery Settings Initialization and Adap…
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted33Sep 9, 2022Registry ↗
Mar 6, 2024Control-IQ Technology in Individuals With Type 2 Diabetes
NCT05111301 · Type 2 Diabetes Treated With Insulin
Control-IQ technology 1.5
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted30Aug 10, 2022Registry ↗
Jan 11, 2024Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes
NCT05973422 · Type 1 Diabetes
SIGI Insulin Management System
TNDM
Tandem Diabetes Care, Inc.
Not applicableUnknown10Sep 30, 2024Registry ↗
Dec 8, 2023Control-IQ Observational (CLIO) Post-Approval Study
NCT04503174 · Diabetes Mellitus, Type 1
t:slim X2 pump with Control-IQ technology
TNDM
Tandem Diabetes Care, Inc.
—Completed3,157Jun 2, 2023Registry ↗
Dec 8, 2023Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial
NCT03195140 · Diabetes Mellitus, Type 1
Predictive Low Glucose Suspend
TNDM
Tandem Diabetes Care, Inc.
Not applicableCompleted103Feb 6, 2018Registry ↗
Sep 1, 2016Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
NCT02877771 · Diabetes Mellitus, Type 1 Diabetes
t:slim insulin pump with predictive low glucose suspend
TNDM
Tandem Diabetes Care, Inc.
Phase 1Completed10Aug 2016Registry ↗

17 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 9:12 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances